학술논문
Efficacy, tolerability and safety of the treatment with teberif: The results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received dmt, after switching from other interferon β-1a
Document Type
Article
Author
Boyko, A.N.; Bosenko, L.P.; Vasilovskiy, V.V.; Lekomtseva, E.V.; Volkova, L.I.; Zakharova, M.N.; Kotov, S.V.; Negrich, T.I.; Parshina, E.V.; Patrusheva, O.P.; Prokopenko, S.V.; Sazonov, D.V.; Timchenko, L.V.; Trinitatskiy, Y.; Khabirov, F.A.; Khavunka, M.; Chichanovskaya, L.V.; Sherman, M.A.; Ivanov, R.A.; Lin’kova, Y.; Stukalina, E.Y.; Zinkina-Orikhan, A.V.; Obukhova, I.G.
Source
In: Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova . (Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, 2019, 119(2):73-85)
Subject
Language
English
ISSN
23094729
19977298
19977298